Sign In
Buy LNTH
$100.25
+3.95 (+4.10%)
At Close: Jun 03, 2026
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
08:30am, Wednesday, 03'rd Jun 2026
BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping cli
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI's Image of the Year
08:00am, Tuesday, 02'nd Jun 2026
BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight a
Lantheus to Present at the William Blair 46th Annual Growth Stock Conference
08:30am, Wednesday, 27'th May 2026
BEDFORD, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clin
Lantheus weighs potential $7 billion sale, Bloomberg News reports
04:27pm, Friday, 22'nd May 2026
Lantheus Holdings is weighing a potential sale after getting a takeover offer from private-equity backed Curium Pharma that could value it at about $7 billion, Bloombe
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting
08:30am, Thursday, 21'st May 2026
BEDFORD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight a
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
08:30am, Tuesday, 19'th May 2026
BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight a
Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders
09:20am, Thursday, 14'th May 2026
Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs and hunt for growth.
Lantheus Q1 Earnings Call Highlights
04:13pm, Friday, 08'th May 2026
Lantheus NASDAQ: LNTH reported what management described as a strong start to 2026, citing solid performance from its three core commercial products—PYLARIFY, Neuraceq® and DEFINITY—and progress
These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results
10:59am, Friday, 08'th May 2026
Lantheus Holdings Inc (NASDAQ:LNTH) reported upbeat earnings for the first quarter on Thursday.
Lantheus Holdings, Inc. (LNTH) Q1 2026 Earnings Call Transcript
10:31pm, Thursday, 07'th May 2026
Lantheus Holdings, Inc. (LNTH) Q1 2026 Earnings Call Transcript
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
07:00am, Thursday, 07'th May 2026
BEDFORD, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to F
Brown Advisory Small Cap Growth Strategy Q1 2026 Portfolio Activity
06:53am, Wednesday, 29'th Apr 2026
Shares of Lantheus Holdings were added after the company received FDA approval of its key product TruVu. We used recent weakness as an opportunity to initiate a position in Talen Energy, an independen
Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Consensus Recommendation of “Moderate Buy” by Brokerages
04:50am, Thursday, 09'th Apr 2026
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH - Get Free Report) have received an average rating of "Moderate Buy" from the eleven research firms that are currently covering the firm, MarketBeat Rat
Lantheus Holdings: Tensions From The PDUFA Extension
08:53am, Tuesday, 07'th Apr 2026
Lantheus Holdings faces a three-month FDA PDUFA extension for OCTEVY, delaying potential approval and launch to June 2026. OCTEVY's extension is procedural, tied to manufacturing review, not efficacy
Lantheus (NASDAQ:LNTH) & High Tide (NASDAQ:HITI) Financial Contrast
02:37am, Wednesday, 25'th Mar 2026
Lantheus (NASDAQ: LNTH - Get Free Report) and High Tide (NASDAQ: HITI - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the st
